KK8398
Phase 3RecruitingInterest: 47/100
47
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Achondroplasia
Conditions
Achondroplasia
Trial Timeline
Dec 1, 2024 → May 31, 2031
NCT ID
NCT06926491About KK8398
KK8398 is a phase 3 stage product being developed by Kyowa Kirin for Achondroplasia. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06926491. Target conditions include Achondroplasia.
What happened to similar drugs?
0 of 2 similar drugs in Achondroplasia were approved
Approved (0) Terminated (0) Active (2)
Hype Score Breakdown
Clinical
17
Activity
15
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT06926491 | Phase 3 | Recruiting |
Competing Products
20 competing products in Achondroplasia